Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms

Apigenin (4,’5,7-trihydroxyflavone) is one of the most studied flavonoids with low toxicity and abundantly present phenolic compound in the plant kingdom. The main sources of apigenin are fruits, vegetables, nuts, herbs, honey, and plant-based drinks like tea. Numerous plants produce apigenin as a s...

Full description

Saved in:
Bibliographic Details
Main Authors: Zarina Mushtaq, Nabeelah Bibi Sadeer, Muzzamal Hussain, Mahwish, Suliman A. Alsagaby, Muhammad Imran, Tamseela Mumtaz, Maryam Umar, Ambreen Tauseef, Waleed Al Abdulmonem, Tabussam Tufail, Entessar Al Jbawi, Mohamad Fawzi Mahomoodally
Format: Article
Language:English
Published: Taylor & Francis Group 2023-09-01
Series:International Journal of Food Properties
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/10942912.2023.2236329
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846095428287725568
author Zarina Mushtaq
Nabeelah Bibi Sadeer
Muzzamal Hussain
Mahwish
Suliman A. Alsagaby
Muhammad Imran
Tamseela Mumtaz
Maryam Umar
Ambreen Tauseef
Waleed Al Abdulmonem
Tabussam Tufail
Entessar Al Jbawi
Mohamad Fawzi Mahomoodally
author_facet Zarina Mushtaq
Nabeelah Bibi Sadeer
Muzzamal Hussain
Mahwish
Suliman A. Alsagaby
Muhammad Imran
Tamseela Mumtaz
Maryam Umar
Ambreen Tauseef
Waleed Al Abdulmonem
Tabussam Tufail
Entessar Al Jbawi
Mohamad Fawzi Mahomoodally
author_sort Zarina Mushtaq
collection DOAJ
description Apigenin (4,’5,7-trihydroxyflavone) is one of the most studied flavonoids with low toxicity and abundantly present phenolic compound in the plant kingdom. The main sources of apigenin are fruits, vegetables, nuts, herbs, honey, and plant-based drinks like tea. Numerous plants produce apigenin as a secondary metabolite and its intake is strongly related to its anti-inflammatory propensities. The purpose of present review was to wade through the literature on the anti-inflammatory mechanisms of this metabolite in various diseases and summarize the key objectives as they appear. Existing literature reported that apigenin is a promising candidate in managing a panoply of inflammatory-related diseases including cancer, diabetes, obesity, depression, insomnia, infection, and respiratory, cardiovascular, hepatoprotective, neurodegenerative, and skin diseases. Studies showed that apigenin significantly decreases the secretion of various proinflammatory cytokines specifically tumor necrosis factor (TNF)-α, IL-1β, IL-6, and IL-10. Moreover, apigenin effectively blocks the nitric oxide-mediated cyclooxygenase-2 expression and monocyte attachment and Prostaglandin by lowering iNOS and COX-2 in both microglial and macrophage mouse cells. Apigenin can slow the course of nonalcoholic fatty liver disease (NAFLD) in vivo by reducing high fat diet (HFD)-induced deposition of lipids and oxidative stress. It also controlled redox imbalances, suppress neuronal death and showed memory enhancement/learning skills and a reduction of fibrillar amyloid deposits with lowered insoluble Aβ concentrations in vivo. Taken together, it can be argued that apigenin can wane inflammation and thus offers a promising future in slowing down the development of chronic diseases and associated complications.
format Article
id doaj-art-d8b89b4565fd481eb2a71e97d5c3832f
institution Kabale University
issn 1094-2912
1532-2386
language English
publishDate 2023-09-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Food Properties
spelling doaj-art-d8b89b4565fd481eb2a71e97d5c3832f2025-01-02T10:41:35ZengTaylor & Francis GroupInternational Journal of Food Properties1094-29121532-23862023-09-012611914193910.1080/10942912.2023.2236329Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanismsZarina Mushtaq0Nabeelah Bibi Sadeer1Muzzamal Hussain2Mahwish3Suliman A. Alsagaby4Muhammad Imran5Tamseela Mumtaz6Maryam Umar7Ambreen Tauseef8Waleed Al Abdulmonem9Tabussam Tufail10Entessar Al Jbawi11Mohamad Fawzi Mahomoodally12Department of Food Science, Government College University Faisalabad, Faisalabad, PakistanDepartment of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit, MauritiusDepartment of Food Science, Government College University Faisalabad, Faisalabad, PakistanDepartment of Nutritional Sciences, Government College Women University, Faisalabad, PakistanDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, AL-Majmaah, Saudi ArabiaDepartment of Food Science and Technology, University of Narowal, Narowal, PakistanDepartment of Zoology, Government College Women University Faisalabad, Faisalabad, PakistanDepartment of Food Science, Government College University Faisalabad, Faisalabad, PakistanDepartment of Physiology, CMH, Lahore, PakistanDepartment of Pathology, College of Medicine, Qassim University, Buraidah, Saudi ArabiaInstitute of Diet & Nutritional Sciences, The University of Lahore, Lahore, PakistanAgricultural Extension Directorate, MAAR, Damascus, SyriaDepartment of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit, MauritiusApigenin (4,’5,7-trihydroxyflavone) is one of the most studied flavonoids with low toxicity and abundantly present phenolic compound in the plant kingdom. The main sources of apigenin are fruits, vegetables, nuts, herbs, honey, and plant-based drinks like tea. Numerous plants produce apigenin as a secondary metabolite and its intake is strongly related to its anti-inflammatory propensities. The purpose of present review was to wade through the literature on the anti-inflammatory mechanisms of this metabolite in various diseases and summarize the key objectives as they appear. Existing literature reported that apigenin is a promising candidate in managing a panoply of inflammatory-related diseases including cancer, diabetes, obesity, depression, insomnia, infection, and respiratory, cardiovascular, hepatoprotective, neurodegenerative, and skin diseases. Studies showed that apigenin significantly decreases the secretion of various proinflammatory cytokines specifically tumor necrosis factor (TNF)-α, IL-1β, IL-6, and IL-10. Moreover, apigenin effectively blocks the nitric oxide-mediated cyclooxygenase-2 expression and monocyte attachment and Prostaglandin by lowering iNOS and COX-2 in both microglial and macrophage mouse cells. Apigenin can slow the course of nonalcoholic fatty liver disease (NAFLD) in vivo by reducing high fat diet (HFD)-induced deposition of lipids and oxidative stress. It also controlled redox imbalances, suppress neuronal death and showed memory enhancement/learning skills and a reduction of fibrillar amyloid deposits with lowered insoluble Aβ concentrations in vivo. Taken together, it can be argued that apigenin can wane inflammation and thus offers a promising future in slowing down the development of chronic diseases and associated complications.https://www.tandfonline.com/doi/10.1080/10942912.2023.2236329Apigenincancerflavonoidsoxidative stresschronic diseasesbioactive compounds
spellingShingle Zarina Mushtaq
Nabeelah Bibi Sadeer
Muzzamal Hussain
Mahwish
Suliman A. Alsagaby
Muhammad Imran
Tamseela Mumtaz
Maryam Umar
Ambreen Tauseef
Waleed Al Abdulmonem
Tabussam Tufail
Entessar Al Jbawi
Mohamad Fawzi Mahomoodally
Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms
International Journal of Food Properties
Apigenin
cancer
flavonoids
oxidative stress
chronic diseases
bioactive compounds
title Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms
title_full Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms
title_fullStr Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms
title_full_unstemmed Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms
title_short Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms
title_sort therapeutical properties of apigenin a review on the experimental evidence and basic mechanisms
topic Apigenin
cancer
flavonoids
oxidative stress
chronic diseases
bioactive compounds
url https://www.tandfonline.com/doi/10.1080/10942912.2023.2236329
work_keys_str_mv AT zarinamushtaq therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT nabeelahbibisadeer therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT muzzamalhussain therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT mahwish therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT sulimanaalsagaby therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT muhammadimran therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT tamseelamumtaz therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT maryamumar therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT ambreentauseef therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT waleedalabdulmonem therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT tabussamtufail therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT entessaraljbawi therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms
AT mohamadfawzimahomoodally therapeuticalpropertiesofapigeninareviewontheexperimentalevidenceandbasicmechanisms